Table 2 Comparison of treatments in the gemcitabine-only and cisplatin-gemcitabine group
|  | Group 1 (n = 9, GEM) | Group 2 (n = 21, CIS/GEM) |
|---|---|---|
Time of initiation days; median (IQR) | 48 (38.5–56.5) | 54 (39.5–70.5) |
Number of courses; median | 6 | 8/8 |
Completion rate; % | 98% | 81%/88% |
Dose reduction; no. | 7 | 15 |